Up and Over the Hurdles: Challenges and Controversies in Cardiology

Dr. Melanie Carter, BScPharm, ACPR, PharmD

Clinical Pharmacy Specialist—Cardiology Kelowna General Hospital, Interior Health

This will be an update on new evidence and therapies in cardiology focusing on the SPRINT trial and sacubitril/ valsartan (Entresto). Time will also be spent addressing the clinical controversy of duration of ACE-I/ARB and BB therapy after acute coronary syndrome.


Blue’s Clues—An Update on Antidepressants

Dr. Sue Corrigan, BScPharm, ACPR, PharmD Clinical Pharmacy Specialist—Mental Health Surrey Memorial Hospital, Lower Mainland Pharmacy Services

Antidepressant choices will be reviewed based on available evidence. The pharmacology and evidence for the newest antidepressant on the Canadian market will be discussed. Finally, the latest evidence on the suicide risk warnings with antidepressant use will be reviewed.


HIV therapy update: Progress, Pitfalls and Pearls

Ms. Kathy Lepik, BScPharm, MSc Research Coordinator, Pharmacovigilance Program

BC Centre for Excellence in HIV/AIDS Clinical Pharmacist, Ambulatory Pharmacy St. Paul’s Hospital, Lower Mainland Pharmacy Services

An update on newer antiretroviral drugs and a potpourri of clinical pearls related to recognizing and managing potential antiretroviral drug therapy problems in hospitalized patients.